Kwak, Minsuk
Southard, Kaden M.
Kim, Woon Ryoung
Lin, Annie
Kim, Nam Hyeong
Gopalappa, Ramu
Lee, Hyun Jung
An, Minji
Choi, Seo Hyun
Jung, Yunmin
Noh, Kunwoo
Farlow, Justin
Georgakopoulos, Anastasios
Robakis, Nikolaos K.
Kang, Min K.
Kutys, Matthew L.
Seo, Daeha
Kim, Hyongbum Henry
Kim, Yong Ho
Cheon, Jinwoo
Gartner, Zev J.
Jun, Young-wook
Funding for this research was provided by:
National Research Foundation of Korea (NRF-2021R1F1A1063378, NRF-2018R1A5A1025511, NRF-2017R1A2B3004198, NRF-2019R1A2C1085712)
U.S. Department of Health & Human Services | NIH | National Institute on Aging (5R01NS047229, 5R01AG008200, 1R21AG072232-01, 1R21AG072232-01, 1R21AG072232-01)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R00CA226366, U01CA244109)
National Science Foundation (DBI-1548297)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (1R01GM112081, 1R01GM126542-01, R35GM134948)
Article History
Received: 5 October 2021
Accepted: 19 October 2022
First Online: 1 December 2022
Competing interests
: Z.J.G. is an equity holder in Scribe Biosciences and Provenance Bio and is an advisor for Serotiny. Y.H.K. is a vice president of, and has a financial interest in, Imnewrun. J.F. is a co-founder and a chief technology officer of, and has a financial interest in, Serotiny. The other authors declare no competing interests.